Xylem (NYSE:XYL) Price Target Raised to $162.00

Xylem (NYSE:XYL) had its price objective upped by investment analysts at Royal Bank of Canada from $157.00 to $162.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Royal Bank of Canada’s price objective indicates a potential upside of 18.07% from the company’s previous close.

XYL has been the subject of several other research reports. Mizuho boosted their price target on shares of Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a report on Friday. Oppenheimer upped their target price on Xylem from $142.00 to $147.00 and gave the stock an “outperform” rating in a report on Friday. BNP Paribas assumed coverage on Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price on the stock. Stifel Nicolaus boosted their price target on Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. Finally, Citigroup raised their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus target price of $140.70.

Xylem Stock Performance

Xylem stock opened at $137.21 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.30 and a current ratio of 1.67. The company has a market capitalization of $33.26 billion, a PE ratio of 48.83, a P/E/G ratio of 2.67 and a beta of 1.08. The company has a 50 day moving average price of $128.64 and a 200-day moving average price of $115.36. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $138.46.

Xylem (NYSE:XYL) last issued its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The business had revenue of $2.03 billion during the quarter, compared to analyst estimates of $2 billion. During the same period in the previous year, the company posted $0.72 EPS. Xylem’s revenue was up 40.4% on a year-over-year basis. As a group, equities analysts forecast that Xylem will post 4.2 earnings per share for the current year.

Insider Transactions at Xylem

In other news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Xylem

Hedge funds have recently made changes to their positions in the company. Bruce G. Allen Investments LLC acquired a new position in shares of Xylem in the 4th quarter valued at $27,000. FinTrust Capital Advisors LLC increased its position in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares during the period. Hazlett Burt & Watson Inc. increased its position in shares of Xylem by 184.9% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after acquiring an additional 220 shares during the period. NBC Securities Inc. acquired a new position in shares of Xylem in the 3rd quarter valued at $38,000. Finally, Spire Wealth Management increased its position in shares of Xylem by 370.9% in the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock valued at $54,000 after acquiring an additional 382 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.